Procept Biorobotics
PROCEPT BioRobotics Corp is a surgical robotics medical technology enterprise headquartered in San Jose, California. The company designs, develops, and commercializes advanced robotic systems for urological surgery and minimally invasive interventions. Its flagship product, the Aquabeam System, utilizes automated waterjet technology for targeted tissue ablation during benign prostatic hyperplasia treatments. Principal revenue is derived through capital sales of robotic surgical consoles, disposable handpiece accessories, and service maintenance contracts. The enterprise serves hospitals, surgical centers, and urology specialists. PROCEPT BioRobotics Corp is publicly listed on the Nasdaq Stock Market.
8 of the funds FundTelligence covers report a position in Procept Biorobotics.
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 8
- Exposure themes
- Healthcare, Robotics & Automation, Surgical Robotics
Funds holding Procept Biorobotics
- BNP Health Care Innovators — BNP Paribas · 0.92 % (full portfolio disclosed, June 2026)
- BNP US Small Cap — BNP Paribas · 0.56 % (full portfolio disclosed, June 2026)
- MetaSpace Fund — NOWO Fund Management · 0.22 % (full portfolio disclosed, June 2026)
- T. Rowe Price US Smaller Companies Equity Fund — T. Rowe Price · 0.14 % (full portfolio disclosed, September 2026)
- Baillie Gifford Worldwide Positive Change Fund — Baillie Gifford · 0.14 % (full portfolio disclosed, September 2026)
- Mercer Global Small Cap Equity Fund — Mercer · 0.1 % (full portfolio disclosed, December 2025)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.02 % (full portfolio disclosed, October 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.01 % (partially disclosed portfolio, June 2026)